Third-Quarter Indian Results Roundup: Alkem, Neuland, JB, Zydus And Natco

Several Indian firms have posted growth in their financial third quarters ended 31 December 2018. Alkem’s International sales manage to offset a slide in its domestic turnover, Neuland picks up momentum despite the impact of raw material price increases, while a better product mix in India works in JB’s favor. Zydus obtains a raft of US product approvals and lays out its approach for generics and biosimilars across the globe, while Natco focuses on complex generics in Canada and Brazil.